Deoxynivalenol and Its Modified Forms: Are There Major Differences?

Deoxynivalenol: mechanisms of action, human exposure, and toxicological relevance. Arch Toxicol (2010) 2.58

Human milk oligosaccharides: every baby needs a sugar mama. Glycobiology (2012) 2.09

Masked mycotoxins: determination of a deoxynivalenol glucoside in artificially and naturally contaminated wheat by liquid chromatography-tandem mass spectrometry. J Agric Food Chem (2005) 2.03

Masked mycotoxins: a review. Mol Nutr Food Res (2012) 1.92

From the gut to the brain: journey and pathophysiological effects of the food-associated trichothecene mycotoxin deoxynivalenol. Toxins (Basel) (2013) 1.71

Mycotoxins: occurrence, toxicology, and exposure assessment. Food Chem Toxicol (2013) 1.68

Formation, determination and significance of masked and other conjugated mycotoxins. Anal Bioanal Chem (2009) 1.61

Trichothecenes: from simple to complex mycotoxins. Toxins (Basel) (2011) 1.59

Comparative cytotoxicity of deoxynivalenol, nivalenol, their acetylated derivatives and de-epoxy metabolites. Food Chem Toxicol (2004) 1.55

The food contaminant deoxynivalenol, decreases intestinal barrier permeability and reduces claudin expression. Toxicol Appl Pharmacol (2009) 1.51

Hydrolytic fate of deoxynivalenol-3-glucoside during digestion. Toxicol Lett (2011) 1.47

Deoxynivalenol and its toxicity. Interdiscip Toxicol (2010) 1.27

Toxicity of deoxynivalenol and its acetylated derivatives on the intestine: differential effects on morphology, barrier function, tight junction proteins, and mitogen-activated protein kinases. Toxicol Sci (2012) 1.26

Vulnerability of polarised intestinal porcine epithelial cells to mycotoxin deoxynivalenol depends on the route of application. PLoS One (2011) 1.24

Proposal of a comprehensive definition of modified and other forms of mycotoxins including "masked" mycotoxins. Mycotoxin Res (2014) 1.21

Occurrence of deoxynivalenol and its 3-beta-D-glucoside in wheat and maize. Food Addit Contam Part A Chem Anal Control Expo Risk Assess (2009) 1.21

Deoxynivalenol transport across human intestinal Caco-2 cells and its effects on cellular metabolism at realistic intestinal concentrations. Toxicol Lett (2006) 1.18

Metabolism of the masked mycotoxin deoxynivalenol-3-glucoside in rats. Toxicol Lett (2012) 1.14

Effect of deoxynivalenol and other Type B trichothecenes on the intestine: a review. Toxins (Basel) (2014) 1.11

Deoxynivalenol-induced proinflammatory gene expression: mechanisms and pathological sequelae. Toxins (Basel) (2010) 1.06

Galacto-oligosaccharides and long-chain fructo-oligosaccharides as prebiotics in infant formulas: a review. Acta Paediatr Suppl (2005) 1.06

The human fecal microbiota metabolizes deoxynivalenol and deoxynivalenol-3-glucoside and may be responsible for urinary deepoxy-deoxynivalenol. Appl Environ Microbiol (2013) 1.05

Determinants of urinary deoxynivalenol and de-epoxy deoxynivalenol in male farmers from Normandy, France. J Agric Food Chem (2010) 1.03

Both direct and indirect effects account for the pro-inflammatory activity of enteropathogenic mycotoxins on the human intestinal epithelium: stimulation of interleukin-8 secretion, potentiation of interleukin-1beta effect and increase in the transepithelial passage of commensal bacteria. Toxicol Appl Pharmacol (2007) 1.03

In vitro effect of deoxynivalenol on the differentiation of human colonic cell lines Caco-2 and T84. Mycopathologia (1998) 1.02

Deoxynivalenol: a trigger for intestinal integrity breakdown. FASEB J (2014) 0.95

Trichothecenes: structure-toxic activity relationships. Curr Drug Metab (2013) 0.95

Prebiotic oligosaccharides reduce proinflammatory cytokines in intestinal Caco-2 cells via activation of PPARγ and peptidoglycan recognition protein 3. J Nutr (2011) 0.95

Effect of cooking process on the deoxynivalenol content and its subsequent cytotoxicity in wheat products. Biosci Biotechnol Biochem (2006) 0.94

Galacto-oligosaccharides are bifidogenic and safe at weaning: a double-blind randomized multicenter study. J Pediatr Gastroenterol Nutr (2009) 0.94

Metabolic pathways of trichothecenes. Drug Metab Rev (2010) 0.92

Anti-inflammatory properties of heat shock protein 70 and butyrate on Salmonella-induced interleukin-8 secretion in enterocyte-like Caco-2 cells. Clin Exp Immunol (2005) 0.88

Intestinal toxicity of the masked mycotoxin deoxynivalenol-3-β-D-glucoside. Arch Toxicol (2015) 0.87

Trichothecene genotypes and production profiles of Fusarium graminearum isolates obtained from barley cultivated in Argentina. Int J Food Microbiol (2014) 0.86

Annual variation of dietary deoxynivalenol exposure during years of different Fusarium prevalence: a pilot biomonitoring study. Food Addit Contam Part A Chem Anal Control Expo Risk Assess (2014) 0.86

Human biomonitoring of multiple mycotoxins in the Belgian population: Results of the BIOMYCO study. Environ Int (2015) 0.85

Galacto-oligosaccharides Protect the Intestinal Barrier by Maintaining the Tight Junction Network and Modulating the Inflammatory Responses after a Challenge with the Mycotoxin Deoxynivalenol in Human Caco-2 Cell Monolayers and B6C3F1 Mice. J Nutr (2015) 0.83

Comparative study of deoxynivalenol, 3-acetyldeoxynivalenol, and 15-acetyldeoxynivalenol on intestinal transport and IL-8 secretion in the human cell line Caco-2. Toxicol In Vitro (2013) 0.83

Physio-pathological parameters affect the activation of inflammatory pathways by deoxynivalenol in Caco-2 cells. Toxicol In Vitro (2010) 0.82

Exposure assessment approach through mycotoxin/creatinine ratio evaluation in urine by GC-MS/MS. Food Chem Toxicol (2014) 0.79

The mycotoxin deoxynivalenol facilitates allergic sensitization to whey in mice. Mucosal Immunol (2016) 0.78

Deoxynivalenol Impairs Weight Gain and Affects Markers of Gut Health after Low-Dose, Short-Term Exposure of Growing Pigs. Toxins (Basel) (2015) 0.81